# A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition

> **NCT01383330** · PHASE1 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** megace
- **DRUG:** DW-ES(A)
- **DRUG:** DW-ES(B)

## Key facts

- **NCT ID:** NCT01383330
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2011-09
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383330, "A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01383330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*